Purple Biotech Ltd ADR [NASDAQ: PPBT] slipped around -0.64 points on Thursday, while shares priced at $0.78 at the close of the session, down -45.07%.
Purple Biotech Ltd ADR stock is now -92.02% down from its year-to-date (YTD) trading value. PPBT Stock saw the intraday high of $0.9153 and lowest of $0.715 per share. The company’s 52-week high price is 13.95, which means current price is +9.09% above from all time high which was touched on 01/02/25.
Compared to the average trading volume of 111.09K shares, PPBT reached a trading volume of 47007078 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Purple Biotech Ltd ADR [PPBT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PPBT shares is $34.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PPBT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.07, with the Price to Cash per share for the same quarter was set at 1.95.
How has PPBT stock performed recently?
Purple Biotech Ltd ADR [PPBT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -64.86. With this latest performance, PPBT shares dropped by -65.49% in over the last four-week period, additionally sinking by -73.01% over the last 6 months – not to mention a drop of -83.37% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PPBT stock in for the last two-week period is set at 12.92, with the RSI for the last a single of trading hit 0.2736, and the three-weeks RSI is set at 0.2173 for Purple Biotech Ltd ADR [PPBT]. The present Moving Average for the last 50 days of trading for this stock 2.2705, while it was recorded at 1.5760 for the last single week of trading, and 2.8521 for the last 200 days.
Purple Biotech Ltd ADR (PPBT) Capital Structure & Debt Analysis
According to recent financial data for Purple Biotech Ltd ADR. ( PPBT), the Return on Equity (ROE) stands at -8.59%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -7.48%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Purple Biotech Ltd ADR’s Return on Invested Capital (ROIC) is -8.23%, showcasing its effectiveness in deploying capital for earnings.
Purple Biotech Ltd ADR (PPBT) Efficiency & Liquidity Metrics
Based on Purple Biotech Ltd ADR’s (PPBT) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Purple Biotech Ltd ADR (PPBT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Purple Biotech Ltd ADR. (PPBT) effectively leverages its workforce, generating an average of -$292222.22 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.88% and a Quick Ratio of 2.88%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Purple Biotech Ltd ADR [PPBT]
With the latest financial reports released by the company, Purple Biotech Ltd ADR posted -1.37/share EPS, while the average EPS was predicted by analysts to be reported at -0.06/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -1.31. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PPBT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Purple Biotech Ltd ADR go to 50.64%.
Insider trade positions for Purple Biotech Ltd ADR [PPBT]
There are presently around $1.89%, or 1.89%% of PPBT stock, in the hands of institutional investors. The top three institutional holders of PPBT stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.36 million shares, which is approximately 5.2352%. KINGSWOOD WEALTH ADVISORS, LLC, holding 0.21 million shares of the stock with an approximate value of $$84680.0 in PPBT stocks shares; and KINGSWOOD WEALTH ADVISORS, LLC, currently with $$10221.0 in PPBT stock with ownership which is approximately 0.0949%.
